title: Myxobacterial metabolites enhance cell proliferation and reduce intracellular stress in cells from a Parkinson's disease mouse model.
abstract: Parkinson's disease is a degenerative disorder of the central nervous system and is regarded as one of the most common neurologic diseases. Myxobacterial metabolites have been shown to possess a wide range of beneficial physiological effects, including anti-fungal, antibiotic, and anti-tumor activities. We aimed to determine whether myxobacterial metabolites exhibit a potential therapeutic effect in cells from a Parkinson's disease mouse model. The screening process identified 4 compounds, which were found to increase cell growth rate by >1.3 times that observed on the vehicle. These compounds promoted regeneration of the cells from a Parkinson's mouse model following the appearance of acute lesions, and reduced the levels of proteins associated with endoplasmic reticulum stress and apoptotic cell death. These compounds could lead to the development of novel therapies for Parkinson's disease and provide insight into the mechanisms through which apoptotic cell death takes place in this disorder.
authors.affiliation: Department of Biotechnology, Hoseo University, Baebang, Asan, Chungnam, Republic of Korea.
authors.forename: Sung-Jo
authors.initials: SJ
authors.lastname: Kim
authors.forename: Yea-Jin
authors.initials: YJ
authors.lastname: Lee
authors.forename: June-Bum
authors.initials: JB
authors.lastname: Kim
mesh_terms: D000818:Animals; D001685:Biological Factors / Q000378:metabolism / Q000627:therapeutic use; D001691:Biological Therapy; D001921:Brain / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation; D002478:Cells, Cultured; D059865:Endoplasmic Reticulum Stress; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006801:Humans; D051379:Mice; D009231:Myxococcales / Q000378:metabolism*; D020734:Parkinsonian Disorders / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D014945:Wound Healing
chemical_list: D001685:Biological Factors